2-85343355-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017750.4(RETSAT):āc.1720G>Cā(p.Val574Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017750.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RETSAT | NM_017750.4 | c.1720G>C | p.Val574Leu | missense_variant | 11/11 | ENST00000295802.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RETSAT | ENST00000295802.9 | c.1720G>C | p.Val574Leu | missense_variant | 11/11 | 1 | NM_017750.4 | P1 | |
RETSAT | ENST00000429806.5 | c.*107G>C | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 1 | ||||
RETSAT | ENST00000449375.1 | c.1087G>C | p.Val363Leu | missense_variant | 8/8 | 5 | |||
RETSAT | ENST00000438611.4 | c.*695G>C | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 5 |
Frequencies
GnomAD3 genomes Cov.: 36
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251254Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135856
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461698Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727136
GnomAD4 genome Cov.: 36
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 02, 2023 | The c.1720G>C (p.V574L) alteration is located in exon 11 (coding exon 11) of the RETSAT gene. This alteration results from a G to C substitution at nucleotide position 1720, causing the valine (V) at amino acid position 574 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at